Quantitative assessment of grammar in amyloid-negative logopenic aphasia
Sign Up to like & getrecommendations! Published in 2018 at "Brain and Language"
DOI: 10.1016/j.bandl.2018.09.003
Abstract: HighlightsAmyloid‐negative lvPPA subjects have a unique linguistic profile.Amyloid‐negative lvPPA has some language features similar to amyloid‐positive.Amyloid‐negative lvPPA also shares language features with agrammatic PPA.The speech of lvPPA can help distinguish amyloid‐negative versus‐positive subjects. Abstract Logopenic… read more here.
Keywords: lvppa; negative lvppa; amyloid negative; language ... See more keywords
The cerebellum could serve as a potential imaging biomarker of dementia conversion in patients with amyloid‐negative amnestic mild cognitive impairment
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Neurology"
DOI: 10.1111/ene.14770
Abstract: As part of network‐specific neurodegeneration, changes in cerebellar gray matter (GM) volume and impaired cerebello–cerebral functional networks have been reported in Alzheimer disease (AD). Compared with healthy controls, a volume loss in the cerebellum has… read more here.
Keywords: amyloid negative; cognitive impairment; dementia conversion; cerebellum ... See more keywords
Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults
Sign Up to like & getrecommendations! Published in 2018 at "Neurology"
DOI: 10.1212/wnl.0000000000006469
Abstract: Objective To assess whether global or regional changes in amyloid burden over 4 years predict early declines in episodic memory in initially amyloid-negative adults. Methods One hundred twenty-six initially amyloid-negative, cognitively normal participants (age 30–89… read more here.
Keywords: negative adults; episodic memory; decline; amyloid negative ... See more keywords
Amyloid-Negative, Neurodegeneration-Negative Amnestic Mild Cognitive Impairment
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-240621
Abstract: Background: The concept of amnestic mild cognitive impairment (aMCI) was developed to identify patients at an initial stage of Alzheimer’s disease (AD). However, some patients with aMCI do not present biomarkers of amyloid pathology or… read more here.
Keywords: negative neurodegeneration; neurodegeneration negative; amyloid negative; amnestic mild ... See more keywords